Araştırma Makalesi

Serum levels of TNF-α and osteoprotegerin and bone mineral density in patients with Behçet’s Disease

Cilt: 39 Sayı: 3 1 Eylül 2012
  • Ali Kutlucan
  • Sevket Ercan Tunc
  • Davut Baltacı
  • Mehmet Sahin
  • Mustafa Ozsahin
  • Recep Sütcü
  • Fatih Ermis
  • Harun Süslü
PDF İndir
EN TR

Serum levels of TNF-α and osteoprotegerin and bone mineral density in patients with Behçet’s Disease

Öz

Objectives: Osteoporosis is commonly developed due to
natural course of Behçet’s disease (BD) and therapeutic
agents. It was aimed to investigate levels of osteoprotegerin
and TNF-α (tumor necrosis factor), and bone mineral density
(BMD) and correlation between them in BD.
Materials and methods: The study included two groups
as the study and the control group. Serum levels of TNF-α,
osteoprotegerin, osteocalcine, erythrocyte sedimentation rate
(ESR), C-reactive protein (CRP), and urinary creatinine and
deoxypyridinoline along with BMD level were evaluated and
compared. Correlation between TNF-α and osteoprotegerin
level was investigated.
Results: The study enrolled 41 BD patients and 36 agedmatched control subjects. Mean age was 42.26±11.64 and
41.66±70.99, in the study and control groups, respectively.
There was no significant difference in body mass index
(BMI) of subjects between groups (p>0.05). Level of TNF-α
(p<0.001), deoxypyridinoline (p<0.001) and osteocalcine
(p=0.041) was significantly higher in the study group compared to the control group. Osteoprotegerin was lower in
BD patients, but the difference was not significant (p>0.05).
Urinary deoxypyridinoline/ urinary creatinine ratio in patients
with BD was significantly higher than those in control group
(p=0.030). Patients had significantly lower BMD comparfed
to the control group, except L2-L4 vertebral area (p<0.001,
p<0.001, p=0.035, p<0.001, p=0.012, p<0.001, p<0.001 and
p=0.111, respectively). No correlation was found between
TNF-α and osteoprotegerin.
Conclusions: The present study indicated that TNF-α and
BMD was negatively correlated with each other and TNF-α
had an effect on osteoporotic process in patients with BD.
Osteoprotegerin level was not decreased, and not correlated
with TNF-α.

Anahtar Kelimeler

Ayrıntılar

Birincil Dil

İngilizce

Konular

Sağlık Kurumları Yönetimi

Bölüm

Araştırma Makalesi

Yazarlar

Ali Kutlucan Bu kişi benim

Sevket Ercan Tunc Bu kişi benim

Davut Baltacı Bu kişi benim

Mehmet Sahin Bu kişi benim

Mustafa Ozsahin Bu kişi benim

Recep Sütcü Bu kişi benim

Fatih Ermis Bu kişi benim

Harun Süslü Bu kişi benim

Yayımlanma Tarihi

1 Eylül 2012

Gönderilme Tarihi

2 Mart 2015

Kabul Tarihi

-

Yayımlandığı Sayı

Yıl 2012 Cilt: 39 Sayı: 3

Kaynak Göster

APA
Kutlucan, A., Tunc, S. E., Baltacı, D., Sahin, M., Ozsahin, M., Sütcü, R., Ermis, F., & Süslü, H. (2012). Serum levels of TNF-α and osteoprotegerin and bone mineral density in patients with Behçet’s Disease. Dicle Medical Journal, 39(3), 325-330. https://doi.org/10.5798/diclemedj.0921.2012.03.0152
AMA
1.Kutlucan A, Tunc SE, Baltacı D, vd. Serum levels of TNF-α and osteoprotegerin and bone mineral density in patients with Behçet’s Disease. diclemedj. 2012;39(3):325-330. doi:10.5798/diclemedj.0921.2012.03.0152
Chicago
Kutlucan, Ali, Sevket Ercan Tunc, Davut Baltacı, vd. 2012. “Serum levels of TNF-α and osteoprotegerin and bone mineral density in patients with Behçet’s Disease”. Dicle Medical Journal 39 (3): 325-30. https://doi.org/10.5798/diclemedj.0921.2012.03.0152.
EndNote
Kutlucan A, Tunc SE, Baltacı D, Sahin M, Ozsahin M, Sütcü R, Ermis F, Süslü H (01 Eylül 2012) Serum levels of TNF-α and osteoprotegerin and bone mineral density in patients with Behçet’s Disease. Dicle Medical Journal 39 3 325–330.
IEEE
[1]A. Kutlucan vd., “Serum levels of TNF-α and osteoprotegerin and bone mineral density in patients with Behçet’s Disease”, diclemedj, c. 39, sy 3, ss. 325–330, Eyl. 2012, doi: 10.5798/diclemedj.0921.2012.03.0152.
ISNAD
Kutlucan, Ali - Tunc, Sevket Ercan - Baltacı, Davut - Sahin, Mehmet - Ozsahin, Mustafa - Sütcü, Recep - Ermis, Fatih - Süslü, Harun. “Serum levels of TNF-α and osteoprotegerin and bone mineral density in patients with Behçet’s Disease”. Dicle Medical Journal 39/3 (01 Eylül 2012): 325-330. https://doi.org/10.5798/diclemedj.0921.2012.03.0152.
JAMA
1.Kutlucan A, Tunc SE, Baltacı D, Sahin M, Ozsahin M, Sütcü R, Ermis F, Süslü H. Serum levels of TNF-α and osteoprotegerin and bone mineral density in patients with Behçet’s Disease. diclemedj. 2012;39:325–330.
MLA
Kutlucan, Ali, vd. “Serum levels of TNF-α and osteoprotegerin and bone mineral density in patients with Behçet’s Disease”. Dicle Medical Journal, c. 39, sy 3, Eylül 2012, ss. 325-30, doi:10.5798/diclemedj.0921.2012.03.0152.
Vancouver
1.Ali Kutlucan, Sevket Ercan Tunc, Davut Baltacı, Mehmet Sahin, Mustafa Ozsahin, Recep Sütcü, Fatih Ermis, Harun Süslü. Serum levels of TNF-α and osteoprotegerin and bone mineral density in patients with Behçet’s Disease. diclemedj. 01 Eylül 2012;39(3):325-30. doi:10.5798/diclemedj.0921.2012.03.0152